Core Insights - The flow cytometer industry in China is projected to reach a market size of approximately 3.599 billion yuan in 2024, reflecting a year-on-year growth of 19.21% [1][9] - The industry is achieving systematic breakthroughs along three main paths: expanding detection limits, enhancing analytical dimensions, and integrating functional platforms [1][9] Industry Overview - Flow cytometers utilize lasers to detect scattered light and fluorescence signals from cells or particles in a high-speed flow state, enabling rapid multi-parameter analysis, sorting, and quantitative characterization [2] - The core principle involves hydrodynamic focusing technology that allows cells to pass through the laser detection area in a single file, capturing forward scatter (indicating cell size), side scatter (indicating internal complexity), and fluorescence signals [2] Industry Development History - The flow cytometer industry in China has evolved over 40 years, starting with the introduction of the first FACS III in 1981, leading to significant milestones in domestic production and technology breakthroughs from 2013 onwards [4] - Key advancements include the introduction of the first clinical spectral flow cytometer and the first flow mass spectrometer with IVD registration, marking significant progress in high-end equipment [4] Market Size - The flow cytometer market is experiencing a shift from laboratory to clinical applications, with a notable increase in market size and technological advancements [9] - Noteworthy innovations include the development of nano-flow technology by Fuliu Biotechnology, which extends detection limits to 24nm, and the NL-CLC spectral flow cytometer by Xiatai Biotechnology, the first clinical-approved full-spectrum product in China [9] Key Companies - Major players in the flow cytometer market include Mindray Medical, which has integrated instruments, reagents, and software into a comprehensive platform, and Fuliu Biotechnology, a leader in nano-flow technology [10][11] - Mindray's revenue for the first three quarters of 2025 was 25.834 billion yuan, a decrease of 12.38% year-on-year, with a net profit of 7.570 billion yuan, down 28.83% [11] Industry Trends - The industry is witnessing accelerated technological iteration, with a focus on high-end and intelligent advancements, including the integration of AI for data analysis and high-throughput sorting [12] - Applications are expanding beyond clinical and research fields into broader industrial and public health areas, such as environmental monitoring and food safety [13] - The domestic production process is accelerating, driven by supply chain security and the need for local alternatives, reshaping the competitive landscape [14]

摘要 ： 近日，安徽中医药大学发布多批政府采购意向，仪器信息网特对其中的仪器设备品目进行梳理， 统计出16项仪器设备采购意向，预算总额达8261万元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 详细采购清单： 安徽中医药大学2 0 2 5 年 6月~ 2 0 2 6年1 月 仪器设备采购 意向汇总表 | | | | 采 | | --- | --- | --- | --- | | 采购 | 需求概况 | 预算 | 购 | | 项目 | | 万元 | 时 | | | | | 间 | | 第一 | | | | | 附属 | 项目审批、核准或备案机关名称：安徽省发展和改革委员会 | | 202 | | 医院 | 批文名称及编号：安徽省发展改革委关于安徽中医药大学第一 | | 6 | | 激光 | | | | | | 附属医院国家中医药传承创新中心项目可行性研究报告(代项 | 398 | 年 | | 共聚 | 目建议书)的复函；皖发改社会函[2023]319号 项目类别：货 | | 1 | | 焦成 | 物。 | | 月 | | 像系 | | ...

编辑丨王多鱼 排版丨水成文 西湖实验室 （生命科学和生物医学浙江省实验室） 是 2020 年 7 月经浙江省人民政府批准设立的首批浙 江省实验室，聚焦生命科学和生物医学，依托 西湖大学 建设， 致力于在基础研究和转化研究方面取得突 破，重点关注 生物医学研究中最突出且最具挑战性的两个领域—— 衰老相关疾病 和 癌症 。 西湖实验室正在公开招聘多个终身轨/终身教职岗位，涵盖所有学术层级。成功入选者还将获任西湖大学兼 职教职。招聘方特别鼓励在 衰老、神经退行 及相关领域 有专长的学者申请。 申请者必须拥有博士学位、医学博士学位或同等学位，具备出色的研究成果记录，有创新的未来研究计 划，能够在本科和研究生教学中取得卓越成就，并致力于在科学实践和教学中促进多元化和包容性社区的 发展。成功入选者将被期望在西湖大学生命科学学院建立充满活力的研究项目，教授研究生和本科生课 程，并参与学院和西湖大学的其他学术活动。 成功申请者将获得具有国际竞争力的薪资和福利、丰厚的启动资金、现代化的实验室空间以及西湖实验室 的先进核心设施的使用权限，包括冷冻电镜、质谱仪、流式细胞仪、光学显微镜、基因组学、代谢组学、 生物信息学和高通量筛选设 ...

Core Viewpoint - The localization of foreign instrument companies in China is accelerating, driven by government policies such as a 20% price discount for eligible products and new regulations from the State Council, leading to a significant transformation in the competitive landscape of the instrument market [2][3]. Group 1: Localization Models - 2025 is identified as the "Year of Localization" for foreign instrument companies, with four primary localization models emerging: 1. **Production Base Localization**: Companies are establishing manufacturing bases in China to enhance responsiveness to market demands and reduce production costs [3][4]. 2. **Innovation and R&D Localization**: Some firms are focusing on local innovation by setting up R&D centers in China to better understand market needs and develop tailored products [5]. 3. **Supply Chain and Cooperation Localization**: Companies are building local supply chains and collaborating with domestic suppliers and research institutions to enhance their integration into the Chinese market [6]. 4. **Key Product Localization Breakthroughs**: Certain companies are achieving breakthroughs in local production of critical medical devices, thereby strengthening their brand presence and market share in China [7]. Group 2: Reshaping Market Competition - The accelerated localization process is reshaping the competitive landscape of China's instrument market, characterized by increased concentration and differentiated competition. Foreign companies maintain dominance in high-end markets due to their technological advantages and brand equity, while local firms are adopting differentiated strategies to compete effectively [8][9]. - Local companies are leveraging cost control, rapid response mechanisms, and flexible customization services to create a niche in the mid-to-low-end market, gradually breaking the monopoly of foreign firms in specific segments [9][10]. - The "Belt and Road" initiative is enabling local companies to leverage cost advantages and geographical familiarity to establish a collaborative competitive landscape with foreign firms in emerging markets, further optimizing the domestic market structure [10]. Group 3: Opportunities and Challenges - The new competitive landscape presents significant opportunities for local companies to upgrade and transform, driven by national policies promoting self-sufficiency in high-end instruments and the growth of downstream industries like smart manufacturing and biomedicine [11]. - However, foreign brands still dominate high-end markets due to their patent barriers and established service ecosystems, posing challenges for local firms in terms of technology gaps and service capabilities [12][13]. - Local companies need to adopt differentiated strategies to navigate this complex environment, focusing on core technology breakthroughs and enhancing their operational efficiency by learning from foreign firms [14].

Core Viewpoint - Beijing Union Medical College plans to procure various laboratory instruments for its 2025 educational equipment update project, with a total budget exceeding 274 million RMB [2][3]. Summary by Sections Procurement Overview - The total budget for the 2025 educational equipment update project is over 274 million RMB, specifically 274.18 million RMB [3]. - The project includes the procurement of flow cytometers, gas chromatography-mass spectrometry systems, triple quadrupole liquid chromatography-mass spectrometry systems, PCR instruments, ultra-pure water systems, and digital scanning microscopes [3]. Specific Equipment and Budgets - The budget for the procurement of 14 flow cytometers is set at 45.375 million RMB [3]. - The first batch of equipment procurement has a budget of 10.48 million RMB, including various simulators and systems [4]. - The second batch has a budget of 37.95 million RMB, including high-temperature gel chromatography and high-resolution liquid chromatography-mass spectrometry systems [4]. - The third batch has a budget of 9.45 million RMB, including PCR instruments and digital pathology workstations [5]. - The fourth batch has a budget of 13 million RMB, including high-content microscopy workstations and 3D bioprinting systems [6]. Import Regulations - Some equipment categories do not allow bids from foreign companies, indicating a focus on domestic suppliers for certain instruments [3]. Submission Deadlines - Various submission deadlines for bids are set throughout December 2025, with specific dates provided for each batch of equipment [4][5][6].

Core Insights - The article highlights the growing importance of flow cytometry in various fields such as life sciences, clinical diagnostics, and biopharmaceutical development, with a projected global market size of $4.721 billion by 2025 and $8.708 billion by 2032, reflecting a CAGR of 9.14% from 2025 to 2032 [2][3] Market Trends - Recent advancements in flow cytometry technologies, including nano-flow, Raman flow, full-spectrum flow, and imaging flow, have significantly expanded the application boundaries of flow cytometers [3] - The integration of automation and artificial intelligence (AI) into flow cytometry is enhancing its capabilities, transforming vast amounts of flow data into actionable scientific insights and clinical decisions [3] Conference Announcement - The 7th Flow Cytometry Network Conference (iCFCM 2025) will be held from October 21-24, 2025, organized by the Instrument Information Network, focusing on new technologies and applications in flow cytometry [3][5] - The conference will feature multiple thematic sessions with presentations from leading scientists and experts in the field, promoting academic and technical exchanges among flow cytometry users [3] Technical Sessions - The conference will cover a range of topics, including mass spectrometry flow cytometry, imaging flow cytometry, and the application of flow cytometry in environmental monitoring and industrial quality control [6][8][9] - Notable sessions will include discussions on high-dimensional flow cytometry, machine learning applications, and the latest advancements in spectral flow cytometry [10][11]

Core Insights - Yunnan University Bio-X Center has allocated 17.36 million yuan for the update of major educational equipment, with seven instrument companies winning bids [2][4]. Summary by Sections Project Overview - The Yunnan University Bio-X Center focuses on interdisciplinary research in biomedical and biopharmaceutical fields, integrating resources from life sciences, medicine, and pharmacy to enhance the synergy between basic research and industrial applications [4]. Bid Results - The procurement results for the major equipment update include four domestic instrument companies and three foreign companies: Dapu Biology, Zircon Photonics, Xiaocroc Biology, Guoyi Quantum, SCIEX, Agilent, and Revvity [3][4]. Domestic Equipment Procurement - The first segment of the domestic equipment procurement was awarded to Yunnan Express Technology Co., Ltd. for 4.66 million yuan, with a total score of 97.51 [5][6]. - The second segment was awarded to Yunnan Yunrui Technology Co., Ltd. for 6.77 million yuan, with a total score of 95.71 [6]. Equipment Details - Key equipment includes: - Flow Cytometer from Dapu Biology, priced at 3,049,300 yuan [6]. - Rapid Ultra-High Resolution Live Cell Imaging System from Zircon Photonics, priced at 2,398,000 yuan [6]. - Molecular Interaction Analysis System from Xiaocroc Biotechnology, priced at 2,999,000 yuan [6]. Imported Equipment Procurement - The first segment of the imported equipment procurement was awarded to Guangdong Keke Instrument Equipment Co., Ltd. for 14.35 million yuan, with a total score of 97.46 [7][8]. - The second segment was awarded to Guoyi Quantum Technology (Hefei) Co., Ltd. for 1.95 million yuan, with a total score of 98.43 [8]. Imported Equipment Details - Key imported equipment includes: - Liquid Chromatography-Mass Spectrometry System from SCIEX, priced at 2,799,000 yuan [8]. - Multi-Mode Imaging System from Agilent, priced at 1,499,000 yuan [8]. - Super-Resolution Live Animal Deep Imaging System from Revvity, priced at 3,999,000 yuan [8]. - Electron Paramagnetic Resonance Spectrometer from Guoyi Quantum, priced at 1,950,000 yuan [8].

Core Insights - The trend of local procurement for scientific reagents in China is increasing, particularly after the pandemic and amid uncertainties in US-China tariff negotiations [2][3] - Domestic companies are gaining market share in the scientific reagent sector, with firms like Titan Technology and Novogene seeing significant stock price increases [2] - The Chinese government is actively promoting the innovation and development of domestic scientific instruments and reagents, aiming for substantial growth in the industry by 2027 [3] Industry Dynamics - Major multinational suppliers of scientific reagents include Thermo Fisher, Merck, Danaher, and Agilent, which have historically dominated the market [2] - Domestic manufacturers are noted for their cost advantages and delivery flexibility, which are becoming increasingly attractive to local drug research and development companies [2][3] - Despite the rise of local firms, multinational companies still maintain a strong technological edge, particularly in high-end products [4][5] Market Trends - The Chinese reagent market is projected to grow by over 10% annually, driven by government support and increasing drug research activities [3] - Multinational companies are responding to market changes by investing in local manufacturing capabilities, such as Merck's €70 million investment in a new reagent production facility in Nantong [5][6] - Collaborations between multinational instrument manufacturers and local reagent companies are emerging, indicating a shift towards integrated solutions in the market [6]

Core Viewpoint - Shanxi Agricultural University has announced multiple government procurement intentions for laboratory instruments, with a total budget of 0.98 billion yuan, indicating a significant investment in research and development capabilities [2][3]. Summary by Sections Procurement Intentions - The university plans to procure four types of laboratory instruments, including ion exchange chromatography, terahertz spectroscopy detection systems, atomic force microscopes for engineering materials, flow cytometers, and real-time fluorescent quantitative PCR instruments, with the expected procurement period from April to August 2025 [3][4]. Instrument Descriptions - **Terahertz Spectroscopy Detection System**: An advanced analytical technology based on terahertz electromagnetic radiation, applicable in materials science, biomedical fields, safety inspections, drug testing, and agricultural quality control, with a frequency range of 0.1 THz to 10 THz [4]. - **Ion Exchange Chromatography**: A liquid chromatography technique based on electrostatic interactions, widely used in biochemistry, pharmaceuticals, environmental analysis, and food science for the separation and purification of ionic or ionizable molecules [5]. - **Real-time Fluorescent Quantitative PCR Instrument**: A precision instrument for real-time monitoring of DNA/RNA amplification during PCR, essential in molecular biology, medical diagnostics, biotechnology, food safety, and environmental monitoring [6]. Research and Development Capacity - Shanxi Agricultural University, established in 1907, is a prominent agricultural institution with a strong focus on agricultural science, integrating multiple disciplines such as biology, environment, and materials science, aimed at promoting agricultural technology innovation and rural revitalization [8][9]. - The university hosts national and provincial key laboratories and engineering research centers, undertaking numerous significant research projects with internationally influential outcomes [9][10]. - The university's research teams focus on solving critical agricultural issues, translating laboratory results into practical applications to ensure national food security and promote sustainable development [10].

Core Viewpoint - The article discusses the procurement project for the Hainan University Cryptography Research Experimental Environment Platform (Phase II) Package A, with a budget of 63,091,500.00 yuan, highlighting the rapid advancements in flow cytometry technology and the structural changes in the industry towards domestic production [1][2]. Group 1: Project Overview - Project Number: HD2025-1-023, Project Name: Hainan University Cryptography Research Experimental Environment Platform (Phase II) Package A, Procurement Method: Competitive Negotiation, Budget Amount: 63,091,500.00 yuan [2]. - The procurement package has a maximum price limit of 63,091,500.00 yuan and requires a bid security of 300,000.00 yuan [2]. Group 2: Procurement Details - The procurement demand includes satellite communication equipment, with a total quantity of 1 batch, and the budget allocated for this item is 63,091,500.00 yuan [2]. - The contract performance period is set for 24 months, with the satellite payload portion to be completed within 12 months [2]. Group 3: Document Acquisition - Procurement documents can be obtained online from June 26, 2025, to July 3, 2025, during specified hours [3]. - Bidders must register on the Hainan Provincial Government Procurement Smart Cloud Platform to download the bidding documents [4]. Group 4: Contact Information - The procurement entity is Hainan University, located at 58 Renmin Avenue, Haikou City, Hainan Province, with contact number 0898-66251770 [6]. - The procurement agency is Huacai Tendering Group Co., Ltd., located at 1-3 Jinlian Road, Longhua District, Haikou City, with contact number 0898-65392579 [6].